Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.21(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1652
-0.0031(-0.26%)
GBP/USD
1.2546
+0.0013(+0.11%)
Bitcoin GBP
50,846.14
+1,645.29(+3.34%)

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

Solid Biosciences Inc. (SLDB)

NasdaqGS - NasdaqGS Real-time price. Currency in USD

Add to watchlist

10.10

-0.13

(-1.27%)

At close: 04:00PM EDT

10.10

0.00

(0.00%)

After hours:

04:00PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	382.39M
Enterprise value	285.02M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	3.65
Price/book (mrq)	3.02
Enterprise value/revenue	-9.59
Enterprise value/EBITDA	-2.80

Trading information

Stock price history

Beta (5Y monthly)	1.94
52-week change ³	89.09%
S&P500 52-week change ³	22.38%
52-week high ³	15.05
52-week low ³	1.81
50-day moving average ³	10.94
200-day moving average ³	6.04

Share statistics

Avg vol (3-month) ³	250.3k
Avg vol (10-day) ³	203.41k
Shares outstanding ⁵	37.86M
Implied shares outstanding ⁶	37.86M
Float ⁸	18.05M
% held by insiders ¹	0.79%
% held by institutions ¹	75.77%
Shares short (15 Apr 2024) ⁴	1.05M
Short ratio (15 Apr 2024) ⁴	3.24
Short % of float (15 Apr 2024) ⁴	5.85%
Short % of shares outstanding (15 Apr 2024) ⁴	2.77%
Shares short (prior month 15 Mar 2024) ⁴	614.94k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	1:15
Last split date ³	28 Oct 2022

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	0.00%

Management effectiveness

Return on assets (ttm)	-30.67%
Return on equity (ttm)	-56.79%

Income statement

Revenue (ttm)	N/A
Revenue per share (ttm)	N/A
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	-101.73M
Net income avi to common (ttm)	-96.02M
Diluted EPS (ttm)	-4.83
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	123.64M
Total cash per share (mrq)	3.28
Total debt (mrq)	26.27M
Total debt/equity (mrq)	20.77%
Current ratio (mrq)	8.94
Book value per share (mrq)	6.20

Cash flow statement

Operating cash flow (ttm)	-94.18M
Levered free cash flow (ttm)	-64.43M